Mylan lowballed Medicaid on EpiPen by $1.27B, far more than its DOJ settlement: HHS
admin 1st June 2017 Uncategorised 0Mylan agreed to a $465 million settlement with the U.S. government last fall in a move to put some of its EpiPen problems in the past. But federal officials say taxpayers suffered $1.27 billion in harms—and that DOJ deal has yet to be finalized.
More: Mylan lowballed Medicaid on EpiPen by .27B, far more than its DOJ settlement: HHS
Source: fierce